Skip to content

Effect of an Education-Centered Digital Multidimensional Management Intervention on Immunosuppressive Medication Adherence in Kidney Transplant Recipients: A Prospective Randomized Controlled Trial

Effect of an Education-Centered Digital Multidimensional Management Intervention on Immunosuppressive Medication Adherence in Kidney Transplant Recipients: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600131476
Enrollment
Unknown
Registered
2026-09-02
Start date
2026-09-14
Completion date
Unknown
Last updated
2026-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Intervention group:Digital multi-dimensional management intervention centered on education can significantly improve the compliance of kidney transplant recipients with immunosuppressant medication, e

Sponsors

Sun Yat-sen Memorial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Adult kidney transplant recipients aged 18 or above; 2.Successfully received allogeneic kidney transplantation surgery, with stable graft function at the time of enrollment; 3.Oral immunosuppressant therapy was maintained for a long time after the operation, and the medication regimen was fixed; 4.Proficient in using mobile communication tools (mobile phones/tablets), and capable of cooperating to complete digital follow-up and online assessment; 5.Clear consciousness, capable of understanding the research content and signing the informed consent form; 6.The expected survival period is >=12 months;

Exclusion criteria

Exclusion criteria: 1.There are severe cognitive impairments and mental illnesses (such as schizophrenia, major depression/anxiety), and they are unable to cooperate in completing research evaluations and interventions. 2.Combined with severe dysfunction of important organs such as the heart, liver and lungs, or serious complications such as malignant tumors and active infections; 3.There are uncontrolled clinical problems such as acute rejection and graft dysfunction after transplantation; 4.Illiterate or unable to understand the content of the scale, unable to complete the self-report assessment; 5.Without a fixed contact method, it is expected that the 12-month follow-up cannot be completed; 6.There are contraindications to research intervention measures or refusal to use digital platforms; 7.Female recipients who are pregnant or breastfeeding;

Design outcomes

Primary

MeasureTime frame
Compliance with immunosuppressant medication;

Secondary

MeasureTime frame
Compliance at different time points;Psychological state (anxiety and depression scores);Stability of immunosuppressive trough concentration;Intervention feasibility indicators;Continuous changes in compliance scores;Health-related quality of life;Renal function indicators;

Countries

China

Contacts

Public ContactWu Haihua

Sun Yat-sen Memorial Hospital

1539379@qq.com+86 20 34070361

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026